DESCRIPTION
Erectile dysfunction (ED) is defined as the inability of the male to achieve or maintain an erection sufficient for sexual intercourse.
EPIDEMIOLOGY
- Massachusetts Male Aging Study (MMAS) revealed that 52% of 1,290 men aged 4070 had some degree of dysfunction, and 10% had total absence of erectile function.
- MMAS revealed a deleterious epidemiologic link between coronary artery disease, diabetes, and ED.
Incidence
The overall incidence rate is estimated at 26 cases per 10,000 man-years; the rate increases with age and the presence of such factors as lower level of education, diabetes, heart disease, and HTN. New cases of specific disease (ED) per population at risk expressed as percentage.
Prevalence
ED affects as many as 30 million men in the United States.
Geriatric Considerations
- The prevalence and incidence is higher in the elderly.
- Higher incidence of predisposing risk factors for ED in the elderly
- Higher sensitivity to the medications that cause ED in the elderly
RISK FACTORS
- Age: Men >40 yr
- HTN with or without treatment (>140/40)
- DM (fasting blood glucose <125 mg 70%)
- Family history of heart disease in primary relative: Male <55
- Elevated LDL cholesterol/triglycerides (>100 mg/dL)
- Low HDL cholesterol (<40 mg/dL)
- Cigarette smoking/passive smoking
- Central obesity associated with the metabolic syndrome
- Physical inactivity
- Elevated homocysteine, lipoprotein(a), C-reactive protein, fibrinogen, factor VIII, factor VII
Genetics
Close link between ED and vascular disease; therefore, polygenic inheritance with clustering of the risk factors in families
GENERAL PREVENTION
- Ideal body weight
- Regular aerobic exercise
- Prevention of endothelial dysfunction through risk factor modification
PATHOPHYSIOLOGY
Plaque starts to clog small arteries in the penis before the arteries in the coronary, cerebral, and peripheral arteries. With sexual stimulation nitric oxide (NO) is released into the corpora cavernosa from nonadrenergic-noncholinergic autonomic nerves and the vascular endothelium. NO stimulates the enzyme guanylate cyclase to produce cyclic guanosine monophosphate (cGMP), which ultimately causes relaxation in the vascular smooth muscle of the arteries, arterioles and sinusoids of the corpora cavernosa, which then fills with blood like a sponge fills with water. The blood is trapped in the penis (tumescence). A frequent underlying cause of ED is lack of cGMP. Erectile dysfunction may occur ~3 yr before coronary events or stroke.
ETIOLOGY
- Unknown; associated with the risks contributing to atherosclerosis
- Causes include alcohol, anticholinergics, antihypertensive (thiazide diuretics, reserpine, -blockers, methyldopa, hydralazine), cancer chemotherapeutics, clofibrate, gemfibrozil, digoxin, statins, H2 receptor antagonists, and tranquilizers. Other causes include:
- Hypogonadism, hypothyroidism, hyperthyroidism, pituitary tumor, hyperprolactinemia
- Cerebrovascular accidents, multiple sclerosis, nerve damage post prostrate surgery, neuropathies, spinal cord injuries
- Peyronie disease, priapism, trauma
- Psychogenic
COMMONLY ASSOCIATED CONDITIONS
- Vascular disease (coronary, cerebral, peripheral)
- DM
- Elevated lipids (total cholesterol >240, HDL >60 was protective)
- Smoking
- HTN
- Obesity
- Sedentary lifestyle
Outline
Signs and symptoms:
- ED is common and increases with age
- Cigarette smoking, diabetes, HTN, hyperlipidemia, cerebral, coronary and peripheral vascular disease, obesity, and sedentary lifestyle are all associated with ED.
- Side effect of various drugs
- Depression, anxiety, and marital discord
Physical Exam
- Directing questions regarding vascular disease, smoking, diabetes, HTN, dyslipidemia, neuropathy, hypertensive medications, and sexual function
- Examination with an eye toward vascular disease and HTN, manifestations of diabetes (end-organ damage; retinopathy, neuropathy and nephropathy)
DIAGNOSTIC TESTS & INTERPRETATION
Lab
Initial lab tests
Fasting lipid profile with serum homocysteine, lipoprotein (a), C-reactive protein, glycosilated Hg, and urinary protein analysis
- BP measurement
- EKG and stress testing to identify coronary and peripheral ischemia
- Carotid US
- Ophthalmologic exam
Imaging
Initial approach
- Noninvasive:
- CXR: Calcification of coronary arteries and aorta
- US to evaluate carotid arteries, peripheral vessels, and abdominal aorta for plaque and aneurysm
- Electron beam CT: Quantify coronary artery calcification to identify plaque burden and location
- Invasive:
- Angiography:
- Intravascular US to evaluate lesion characteristics
- Transesophageal echo to evaluate proximal coronary artery plaque burden and atheromatous disease of the aorta
Diagnostic Procedures/Surgery
- Angioplasty of carotid/coronary/peripheral systems of surgery
- High-risk group for ED
- Careful questioning regarding sexual function in this subset of patients to establish diagnosis of ED and risk-factor reduction as well as treatment options
Outline
FOLLOW-UP RECOMMENDATIONS
- After risk stratification to a low-risk status and initiation of drug therapy or other therapies, the follow-up is yearly with the primary care physician, assuming no side-effects.
- Routine follow-up should include reinforcement of exercise and prevention of endothelial dysfunction through risk-factor modification.
- Symptoms of heart disease should prompt cardiology consultation, and recurrence of ED should prompt urology consultation.
PATIENT EDUCATION
- Encourage exercise, ideal body weight, and risk-factor modification of endothelial dysfunction.
- Discuss side effects of prescribed medication and indications for follow-up. Stress importance of immediate follow-up if cardiovascular symptoms occur.
- Review the interaction between PDE-5 inhibitors and nitrates; also discuss the effect of PDE-5 inhibitors and BP.
- Encourage yearly follow-up for comprehensive medical evaluation, review risk factors, and discuss potential side effects.
Outline
CODES
ICD9
607.84 Impotence of organic origin
SNOMED
398175007 male erectile disorder (disorder)
CLINICAL PEARLS
- Associated conditions that increase the likelihood of ED include vascular disease, diabetes, smoking, obesity, sedentary lifestyle, and abnormal lipid profile.
- Nitrates are absolutely contraindicated for simultaneous use with the PDE-5 inhibitors.
- The most essential component to establishing the diagnosis of ED in the primary care setting is central questioning regarding sexual function in a patient with a high burden of risk factors for endothelial dysfunction.
Outline